Probuphine (buprenorphine)

pCPA File Number: 21061
Negotiation Status:
Concluded with an LOI
Indication(s):
Opioid Use Disorder
Sponsor/Manufacturer:
Knight Therapeutics Inc.
CDA-AMC Project Number:
SR0550-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: